Advancing infectious disease research and public health systems through evidence.
IFAIN conducts rigorous, ethics-approved research across Nigeria and partners internationally to generate data that informs policy, practice, and future interventions.
International Foundation Against
Infectious Disease in Nigeria
Non-Profit Research Institution · Est. 2012 · Abuja
To reduce the burden of infectious diseases in Nigeria by generating high-quality epidemiologic data, strengthening laboratory systems, advancing innovative research and solutions, and building national capacity for health security.
To be the leading hub for innovative research driving effective and sustainable prevention and control of infectious diseases in Nigeria and Africa.
Established in 2012 by Prof. Stephen Obaro, IFAIN has grown from a single NIH-funded study into a multidisciplinary institution conducting 15+ studies across 12+ Nigerian states, with 80+ peer-reviewed publications.
PROF. STEPHEN OBARO
Chief Scientific Officer / FounderMBBS, FWACP, MRCP(UK), FRCPCH, FAAP, PhD, FIDSA, FPIDSA
DR. AJORITSEDERE AWOSIKA
Chairman of BoardPhD, FWAPCP
HON. JUSTICE YARGATA NIMPAR (JCA)
TrusteeJCA
Dr. Akin Fajola
TrusteeMBBS MPH FWACP Dip HSM
Mr. Ademola Adebise
TrusteeB.Sc Computer Science, MBA
Mr. Peter Ameadaji
TrusteeLLB, MBA
Prof. Ehimario Igumbor
Chief Executive Officer
Dr. Bernard Ebruke
Country Director
Nekpen Ogbomo
Chief Operations Officer
DS-I Africa
Data ScienceNational Institutes of Health
Research Funder
Global Vaccine Data Network
Research
Wellcome Sanger Institute
Research
GSK
Pharmaceutical
J. Craig Venter Institute
Genomics
University of Ibadan
Academic
University of Maryland, School of Medicine
Research
GAVI, The Vaccine Alliance
ResearchResearch Portfolio
Active Studies
Community-Acquired Pneumonia and Invasive Bacterial Diseases in Young Nigerian Children
Research Outputs
Peer-Reviewed Publications
80+ peer-reviewed papers in leading international journals.
View Full Library →Emergence of New Delhi Metallo-β-Lactamase (NDM-5) in Klebsiella quasipneumoniae from Neonates in a Nigerian Hospital
Erratum: Status of Retinoids and Carotenoids and Associations with Clinical Outcomes in Maternal-Infant Pairs in Nigeria. Nutrients 2018, 10, 1286
Aetiology of neonatal sepsis in Nigeria, and relevance of Group b streptococcus: A systematic review
Detection of Streptococcus pneumoniae from culture-negative dried blood spots by real-time PCR
Latest
News & Insights
● General News · February 2026
Strengthening Pharmacovigilance
The IFAIN team - Prof Stephen Obaro and Prof Ehimario IGUMBOR recently paid a courtesy visit to the National Agency for Food and Drug Administration and Control (NAFDAC) as part of ongoing efforts to strengthen collaboration in pharmacovigilance and vaccine…
Global Health Partnership
Based on our collaborative project for 2026, the IFAIN team, led by our CEO, Professor…
January 2026Advancing Infectious Disease Surveillance
We recently had the honour of hosting the Director General of the Nigeria Centre for…
february 2026Partner with IFAIN
We welcome collaboration with funders, academic institutions, ethics bodies, and health organisations worldwide.